Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight.
Nikhil NalluriNileshkumar PatelSamer SaoumaViswajit Reddy AnuguDixitha AnugulaDeepak AstiVarshil MehtaVarun KumarVarunsiri AttiSushruth EdlaRasleen K GrewalHafiz M KhanRitesh KanotraGregory ManiatisRuben KandovJames C LaffertyMichael DyalCarlos E AlfonsoMauricio G CohenPublished in: Expert review of medical devices (2017)
Impella is a catheter-based micro-axial flow pump placed across the aortic valve, and it is currently the only percutaneous left ventricular assist device approved for high-risk percutaneous coronary intervention and cardiogenic shock. Areas Covered: Even though several studies have repeatedly demonstrated the excellent hemodynamic profile of Impella in high-risk settings, it remains underutilized. Here we aim to provide an up-to-date summary of the available literature on Impellas use in High risk settings as well as the practical aspects of its usage. Expert Commentary: Percutaneous coronary interventions in high rsk settings have always been challenging for a physician. Impella 2.5 and CP, have been proven safe, cost effective and feasible in High Risk Percutaneous coronary Interventions with an excellent hemodynamic profile.
Keyphrases
- left ventricular assist device
- aortic valve
- ultrasound guided
- coronary artery disease
- minimally invasive
- percutaneous coronary intervention
- aortic stenosis
- extracorporeal membrane oxygenation
- radiofrequency ablation
- coronary artery
- transcatheter aortic valve replacement
- randomized controlled trial
- physical activity
- primary care
- emergency department
- aortic valve replacement
- transcatheter aortic valve implantation
- acute myocardial infarction
- systematic review
- acute coronary syndrome
- st segment elevation myocardial infarction
- heart failure
- coronary artery bypass grafting
- atrial fibrillation
- antiplatelet therapy
- left ventricular
- clinical practice